Alpha 2.0
Login Register
» Authors » Theodoros Marinakis

Theodoros Marinakis

Explore the profile of Theodoros Marinakis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 206
Followers 0
Related Specialties
Hematology
Oncology
Cell Biology
Top 10 Co-Authors
Stefanos I Papadhimitriou
Nikolaos J Tsagarakis
Georgios Paterakis
Vassiliki Pappa
Konstantina Repa
Veroniki Komninaka
Ioannis V Kostopoulos
Evangelos Terpos
Niki Stavroyianni
Ersi Voskaridou
Published In
Blood Cells Mol Dis
Int J Lab Hematol
Cancer
Am J Hematol
Leuk Lymphoma
Affiliations
Soon will be listed here.
Recent Articles
1.
FLAER Revealed Normally Expected Non-PNH FLAER-Dim Immature Myeloid Cells (CD117+/CD34-) In Bone Marrow Aspirates and Could Be Utilized as a Marker of Hierarchical Hematopoiesis
Karela C, Tsagarakis N, Oudatzis G, Xanthopoulos V, Milaiou M, Nikolaou S, et al.
Int J Lab Hematol . 2024 Oct; 47(2):228-235. PMID: 39478200
Introduction: Fluorescently labeled aerolysin (FLAER) is widely used for the identification of paroxysmal nocturnal hemoglobinuria (PNH) clones in peripheral blood (PB) samples. However, there are only a few reports on...
2.
Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
Perpinia A, Kadoglou N, Vardaka M, Gkortzolidis G, Karavidas A, Marinakis T, et al.
Pharmaceuticals (Basel) . 2022 Aug; 15(8). PMID: 36015155
Modern treatment modalities in hematology have improved clinical outcomes of patients with hematological malignancies. Nevertheless, many new or conventional anticancer drugs affect the cardiovascular system, resulting in various cardiac disorders,...
3.
A very rare case of extranodal B-cell non-Hodgkin lymphoma presenting with adrenal and heart involvement
Papanastasiou L, Skarakis N, Vardaka M, Dimitriadi A, Lampropoulou P, Perpinia A, et al.
Leuk Res Rep . 2022 May; 17:100318. PMID: 35539018
We report an extremely rare case of extranodal B-cell NHL: DLBCL (diffuse large B-cell non-Hodgkin lymphoma), stage IVE, presenting with heart and bilateral adrenal involvement. On admission, adrenal and thorax...
4.
The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells
Papadhimitriou S, Terpos E, Liapis K, Pavlidis D, Marinakis T, Kastritis E, et al.
Biomedicines . 2022 Feb; 10(2). PMID: 35203419
Plasma cell leukemia (PCL) is a rare and aggressive plasma cell dyscrasia that may appear as de-novo leukemia (pPCL) or on the basis of a pre-existing multiple myeloma (MM), called...
5.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas
Dimou M, Papageorgiou S, Stavroyianni N, Katodritou E, Tsirogianni M, Kalpadakis C, et al.
Hematol Oncol . 2021 Feb; 39(3):336-348. PMID: 33583077
Transplant-ineligible relapsed/refractory (rr) diffuse large B-cell lymphoma (DLBCL) patients represent an unmet medical need. Polatuzumab vedotin (Pola), an anti-CD79b antibody-drug-conjugate (ADG), with bendamustine- rituximab(BR) has recently gained approval for these...
6.
Outcomes of pregnancies in patients with Gaucher Disease: The experience of a center of excellence on rare metabolic Disease-Gaucher Disease, in Greece
Komninaka V, Flevari P, Marinakis T, Karkaletsis G, Malakou L, Repa K
Eur J Obstet Gynecol Reprod Biol . 2020 Oct; 254:181-187. PMID: 33032100
Objective: Pregnancy is reported to exacerbate manifestations in women with Gaucher Disease (GD). The objective of our study was to examine the outcome of pregnancies of Caucasian women with GD...
7.
Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma
Tsagarakis N, Papadhimitriou S, Pavlidis D, Liapis K, Gortzolidis G, Kostopoulos I, et al.
Cytometry B Clin Cytom . 2020 Jun; 98(5):412-420. PMID: 32497402
Background: There are no immunophenotypic guidelines for the investigation of MYC-rearranged lymphomas. We aimed to identify simple immunophenotypic features that would help to differentiate between MYC-rearranged lymphomas and guide cytogenetic...
8.
Platelet function defects in patients with Gaucher disease on long term ERT- implications for evaluation at bleeding challenges
Komninaka V, Repa K, Marinakis T, Pouliakis A, Koutsouri T, Tsokanas D, et al.
Blood Cells Mol Dis . 2019 Nov; 80:102371. PMID: 31670186
No abstract available.
9.
Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia
Tsagarakis N, Papadhimitriou S, Pavlidis D, Marinakis T, Kostopoulos I, Stiakaki E, et al.
Int J Lab Hematol . 2019 Feb; 41(3):364-372. PMID: 30730614
Introduction: In B-acute lymphoblastic leukemia (B-ALL), the identification of cytogenetic prognostic factors is important for stratifying patients into risk groups and tailoring treatment accordingly. The purpose of this study was...
10.
ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics
Kakosaiou K, Panitsas F, Daraki A, Pagoni M, Apostolou P, Ioannidou A, et al.
Leuk Lymphoma . 2018 Feb; 59(10):2439-2446. PMID: 29411666
Mutations of ASXL1 are early events in acute myeloid leukemia (AML) leukemogenesis and have been associated with unfavorable prognosis. In this study, we investigated the type and frequency of ASXL1...